Central Florida Pulmonary is categorized under Internal Medicine Practitioners in Orlando, FL and active since 2007.
Central Florida Pulmonary was established in 2007, and today employs 1 to 4, earning $1.000.000 to $2.499.999 per year. This is a Internal Medicine Practitioners business, which does work in the B2C market, and is classified as a Internal Medicine Practitioners, under code number 6211110 by the NAICS.
If you are seeking more information, feel free to contact at the company’s single location by writing to 10916 Dylan Loren Circle, Orlando, Florida FL 32825 or by phoning (407) 841-1100. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Central Florida Pulmonary |
| Address: | 10916 Dylan Loren Circle, Orlando, Florida 32825 |
| Phone Number: | (407) 841-1100 |
| Website Address: | cfpulmonary.com |
| Annual Revenue (USD): | $1.000.000 to $2.499.999 |
| Founded: | 2007 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Internal Medicine Practitioners |
| SIC Code: | 8011 |
| NAICS Code: | 6211110 |
| Share This Business: |
Central Florida Pulmonary was started in 2007 to provide professional Internal Medicine Practitioners under the SIC code 8011 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $1.000.000 to $2.499.999 per annum.
Feel free to contact for inquiries that concern Central Florida Pulmonary by calling the company number (407) 841-1100, as your correspondence is most welcome. Additionally, the physical location of the single location of Central Florida Pulmonary can be found at the coordinates 28.5394,-81.22766 as well as the street address 10916 Dylan Loren Circle in Orlando, Florida 32825.
For its online presence, you may visit Central Florida Pulmonary’s website at cfpulmonary.com and engage with its social media outlets through on Twitter and on Facebook.